Dysregulation of lncRNA–miRNA–mRNA Interactome as a Marker of Metastatic Process in Ovarian Cancer
И. В. Пронина(Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences), Olga Brovkina(Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences), A. M. Burdennyy(Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences), В. И. Логинов(Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences), Л. А. Урошлев(Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences), Danila M. Zaichenko(Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences), Н. Е. Кушлинский(Russian Cancer Research Center NN Blokhin), Alexey A. Dmitriev(Engelhardt Institute of Molecular Biology), М. В. Фридман(New York University), Alexey A. Moskovtsev(Pirogov Russian National Research Medical University), Е. А. Филиппова, T. P. Kazubskaya(Russian Cancer Research Center NN Blokhin), Э. А. Брага(Research Centre for Medical Genetics)
Cited by 14
Related Papers
ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells
|Oxidative Medicine and Cellular Longevity|2019|895
In vivo measurement of afferent activity with axon-specific calcium imaging
|Nature Neuroscience|2018|249
LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms
|International Journal of Molecular Sciences|2020|230
Landscape of allele-specific transcription factor binding in the human genome
|Nature Communications|2021|204